{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:20:43Z","timestamp":1761409243638,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.pan.2023.06.010","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T21:12:40Z","timestamp":1687209160000},"page":"622-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN)"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7574-9364","authenticated-orcid":false,"given":"Mathias","family":"Brugel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibault","family":"Marulier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9889-1424","authenticated-orcid":false,"given":"Claire","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-9635","authenticated-orcid":false,"given":"David","family":"Tougeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8243-8310","authenticated-orcid":false,"given":"Guillaume","family":"Piessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-4864","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Truant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2282-0101","authenticated-orcid":false,"given":"Anthony","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7296-5464","authenticated-orcid":false,"given":"Nicolas","family":"Williet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Botsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Brasseur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-5471","authenticated-orcid":false,"given":"Marine","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2023.06.010_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.pan.2023.06.010_bib2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ije\/dyaa128","article-title":"Cancer cure for 32 cancer types: results from the EUROCARE-5 study","volume":"49","author":"Dal Maso","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.pan.2023.06.010_bib3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/0284186X.2016.1197419","article-title":"More deaths from pancreatic cancer than breast cancer in the EU by 2017","volume":"55","author":"Ferlay","year":"2016","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.pan.2023.06.010_bib4","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2023.06.010_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"Maisonneuve","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"Suppl 5","key":"10.1016\/j.pan.2023.06.010_bib6","doi-asserted-by":"crossref","first-page":"v56","DOI":"10.1093\/annonc\/mdv295","article-title":"Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Ducreux","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.dld.2018.08.008","article-title":"Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)","volume":"50","author":"Neuzillet","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.pan.2023.06.010_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000493473","article-title":"Familial pancreatic cancer","volume":"41","author":"Benzel","year":"2018","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.pan.2023.06.010_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13053-015-0038-x","article-title":"The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers","volume":"13","author":"Cavanagh","year":"2015","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.pan.2023.06.010_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: estimates for sites other than breast and ovary","volume":"42","author":"van Asperen","year":"2005","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pan.2023.06.010_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00432-018-2666-9","article-title":"Emerging strategies in BRCA-positive pancreatic cancer","volume":"144","author":"Kowalewski","year":"2018","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13053-018-0088-y","article-title":"CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome","volume":"16","author":"Cremin","year":"2018","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.pan.2023.06.010_bib13","first-page":"3667","article-title":"Pancreatic cancer in Lynch syndrome patients","volume":"8","author":"Bujanda","year":"2017","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.pan.2023.06.010_bib14","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamem.2013.04.018","article-title":"EpCAM: structure and function in health and disease","volume":"1828","author":"Schnell","year":"2013","journal-title":"Biochim Biophys Acta"},{"journal-title":"Eur Med Agency","year":"2018","author":"Lynparza","key":"10.1016\/j.pan.2023.06.010_bib15"},{"key":"10.1016\/j.pan.2023.06.010_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2023.06.010_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.pan.2023.06.010_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.pan.2023.06.010_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2023.06.010_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4251\/wjgo.v11.i2.102","article-title":"Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: challenges of daily clinical practice","volume":"11","author":"Fulton","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2022.01.040","article-title":"Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: a French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)","volume":"166","author":"Brugel","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.pan.2023.06.010_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10689-018-0106-2","article-title":"Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma","volume":"18","author":"Walker","year":"2019","journal-title":"Fam Cancer"},{"key":"10.1016\/j.pan.2023.06.010_bib24","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/cncr.31242","article-title":"Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy","volume":"124","author":"Dudley","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2023.06.010_bib25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1245\/s10434-015-5026-x","article-title":"Statewide retrospective review of familial pancreatic cancer in Delaware, and frequency of genetic mutations in pancreatic cancer kindreds","volume":"23","author":"Catts","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib26","doi-asserted-by":"crossref","first-page":"10599","DOI":"10.1200\/JCO.2021.39.15_suppl.10599","article-title":"Compliance with germline testing in pancreatic cancer in a rural tertiary care hospital","volume":"39","author":"Travaline","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2022.40.28_suppl.342","article-title":"Adherence to NCCN screening guidelines for germline testing of patients with pancreatic cancer at a large academic medical center: a retrospective chart review","volume":"40","author":"Rosso","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.pan.2023.06.010_bib29","article-title":"Point\/counterpoint: is it time for universal germline genetic testing for all GI cancers?","volume":"352","author":"Hampel","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib30","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.4_suppl.536","article-title":"Cost-effectiveness of universal screening for germline BRCA mutations in metastatic pancreatic cancer","volume":"40","author":"Ingram","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib31","first-page":"629","article-title":"Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer","volume":"169","author":"Krepline","year":"2021","journal-title":"Surg U S"},{"key":"10.1016\/j.pan.2023.06.010_bib32","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.3390\/cancers13225612","article-title":"Universal germline testing of unselected cancer patients detects pathogenic var iants missed by standard guidelines without increasing healthcare costs","volume":"13","author":"Perkins","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.pan.2023.06.010_bib33","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.21.01604","article-title":"Overall survival results from the POLO trial: a phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer","volume":"40","author":"Kindler","year":"2022","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib34","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1200\/OP.20.00678","article-title":"Implementing systematic genetic counseling and multigene germline testing for individuals with pancreatic cancer","volume":"17","author":"Chittenden","year":"2021","journal-title":"JCO Oncol Pract"},{"year":"2022","series-title":"Oncog\u00e9n\u00e9tique en 2020\/consultations & laboratoires, suivi en 2019 et 2020, collection Appui \u00e0 la d\u00e9cision","key":"10.1016\/j.pan.2023.06.010_bib35"},{"key":"10.1016\/j.pan.2023.06.010_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.e18735","article-title":"Family history assessment to identify patients at risk for hereditary cancer syndromes in community oncology practices","volume":"40","author":"Austin","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10689-020-00160-x","article-title":"Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway","volume":"19","author":"Grindedal","year":"2020","journal-title":"Fam Cancer"},{"key":"10.1016\/j.pan.2023.06.010_bib38","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"0","author":"Sessa","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pan.2023.06.010_bib39","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.6004\/jnccn.2017.0131","article-title":"Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Tempero","year":"2017","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.pan.2023.06.010_bib40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s10897-018-0212-1","article-title":"Comparison of practice guidelines, BRCAPRO, and genetic counselor estimates to identify germline BRCA1 and BRCA2 mutations in pancreatic cancer","volume":"27","author":"Grant","year":"2018","journal-title":"J\u00a0Genet Counsel"},{"key":"10.1016\/j.pan.2023.06.010_bib41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/cge.14100","article-title":"Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system","volume":"101","author":"Powell","year":"2022","journal-title":"Clin Genet"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390323001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390323001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:17:04Z","timestamp":1761409024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390323001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1424390323001874"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2023.06.010","relation":{},"ISSN":["1424-3903"],"issn-type":[{"type":"print","value":"1424-3903"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN)","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2023.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}